Viewing Study NCT05390528


Ignite Creation Date: 2025-12-26 @ 10:32 AM
Ignite Modification Date: 2025-12-31 @ 4:06 PM
Study NCT ID: NCT05390528
Status: UNKNOWN
Last Update Posted: 2023-08-08
First Post: 2022-04-25
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study Evaluating the Safety, Tolerability, Pharmacokinetic and Efficacy of HLX301(TIGIT×PDL1 Bispecific) in Locally Advanced/Metastatic Solid Tumors or Lymphoma
Sponsor: Shanghai Henlius Biotech
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module